Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
GNC > SEC Filings for GNC > Form 10-K on 22-Feb-2013All Recent SEC Filings

Show all filings for GNC HOLDINGS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 10-K for GNC HOLDINGS, INC.


22-Feb-2013

Annual Report


Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

You should read the following discussion in conjunction with Item 6, "Selected Financial Data" and our audited consolidated financial statements and the related notes thereto. The discussion in this section contains forward-looking statements that involve risks and uncertainties. See Item 1A, "Risk Factors" in this Annual Report for a discussion of important factors that could cause actual results to differ materially from those described or implied by the forward-looking statements contained herein. We urge you to review the information set forth in "Forward Looking Statements" and Item 1A, "Risk Factors" included elsewhere in this Annual Report.


Table of Contents

Business Overview

We are a global specialty retailer of health and wellness products. We derive our revenues principally from product sales through our company-owned stores and online through GNC.com and LuckyVitamin.com, domestic and international franchise activities and sales of products manufactured in our facilities to third parties. We sell products through a worldwide network of more than 8,100 locations operating under the GNC brand name.

Executive Overview

In 2012, we continued to focus on achieving our five principal corporate goals: growing company-owned domestic retail earnings, growing company-owned domestic retail square footage, growing our international footprint, expanding our e-commerce business and further leveraging of the GNC brand. These goals are designed to drive both short-term and long-term financial results. Our efforts led to the following results for the year ended December 31, 2012 compared to the same period in 2011:

º •
º Our company-owned domestic same store sales increased by 11.5%, which includes a 28.9% increase from our GNC.com business.

º •
º We increased our company-owned domestic store count by 142 net new stores, or 4.9%.

º •
º Our retail segment sales increased by 17.6%, and operating income increased by 42.3%.

º •
º Total franchising revenue grew 21.9%, and operating income increased by 22.7%.

º •
º Domestic franchising revenue grew 15.7%, and we added 25 net new domestic franchise stores.

º •
º International franchise revenue grew by 28.5%, as we added 240 net new international franchise stores.

º •
º LuckyVitamin.com generated $56.7 million of revenue in 2012 compared to $14.5 million generated following our acquisition in August 2011.

º •
º We increased our sales in our wholesale/manufacturing segment by 8.2% through our wholesale distribution channels and increased third-party sales.

º •
º We generated 17.3% of total revenue growth which drove a 51.7% increase in total operating income.

º •
º During 2012, we expanded our new Gold Card Member Pricing model to additional markets, including New York and Chicago, which evolves Gold Card from a fixed 20% discount the first week of each month to an everyday variable discount Member Pricing model.

º •
º We generated net cash from operating activities of $221.2 million, repurchased $360.0 million in common stock, and paid $45.2 million in common stock dividends.

In March 2011, Centers, a wholly owned subsidiary of Holdings, entered into a senior credit facility, consisting of a $1.2 billion term loan facility (the "Term Loan Facility") and an $80.0 million revolving credit facility (the "Revolving Credit Facility" and, together with the Term Loan Facility, the "Senior Credit Facility"), and utilized the proceeds to repay all outstanding indebtedness under the 2007 Senior Credit Facility, the Senior Notes, and the Senior Subordinated Notes. Subsequently, we completed two amendments to the Term Loan Facility. On August 1, 2012, we amended the Term Loan Facility to increase the outstanding borrowings by $200.0 million (the "Incremental Term Loan"). In October 2012, we amended the Term Loan Facility to adjust the per annum interest rate to the greater of LIBOR and 1.00%, plus an applicable margin of 2.75% (the "Repricing"). The refinancing and these amendments are collectively referred to herein as the "Refinancings." See "Liquidity and Capital Resources: Cash Used in Financing Activities" herein for a further description of these items.


Table of Contents

In April 2011, we consummated the IPO of 25.875 million shares of Holdings' Class A common stock, par value $0.001 per share (the "Class A common stock"), at an IPO price of $16.00 per share. The net proceeds from the IPO, together with cash on hand, were used to redeem all outstanding shares of Holdings' Series A preferred stock, par value $0.001 per share (the "Series A preferred stock"), repay approximately $300.0 million of outstanding borrowings under the Term Loan Facility and pay approximately $11.1 million to satisfy obligations under the Management Services Agreement (as defined in Note 18, "Related Party Transactions") and Holdings' Class B common stock, par value $0.001 per share (the "Class B common stock" and, together with the Class A common stock, the "common stock"). Subsequent to the IPO, certain of Holdings' stockholders completed the following registered offerings of Class A common stock:

º •
º in October 2011, 23.0 million shares at $24.75 per share;

º •
º in March 2012, 19.6 million shares at $33.50 per share;

º •
º in August 2012, 10.0 million shares at $38.42 per share; and

º •
º in November 2012, 11.7 million shares at $35.20 per share.

In conjunction with the August 2012 offering, we repurchased an additional six million shares of Class A common stock from one of our stockholders as part of a share repurchase program. The IPO, the offerings, and the repurchase of the six million shares of Class A common stock are collectively referred to herein as the "Offerings."

On March 19, 2012, OTPP converted all of its shares of Class B common stock into an equal number of shares of Class A common stock. There were no shares of Class B common stock outstanding at December 31, 2012.

As of December 31, 2012, we had completed our approved share repurchase programs for a total of $360.0 million of Class A common stock.

Revenues and Operating Performance from our Segments

We measure our operating performance primarily through revenues and operating income from our three segments, Retail, Franchise and Manufacturing/Wholesale, and through the management of unallocated costs from our warehousing, distribution and corporate segments, as follows:

º •
º Retail: Retail revenues are generated by sales to consumers at our company-owned stores and online through our websites GNC.com and LuckyVitamin.com. Although we believe that our retail and franchise businesses are not seasonal in nature, historically we have experienced, and expect to continue to experience, a variation in our net sales and operating results from quarter to quarter. Our industry is expected to grow at an annual average rate of approximately 6.5% through 2020. As a leader in our industry, we expect our organic retail revenue to grow faster than the projected industry growth as a result of our disproportionate market share, scale economies in purchasing and advertising, strong brand awareness and vertical integration.

º •
º Franchise: We generate franchise revenues primarily by:

º (1)
º product sales to our franchisees;

º (2)
º royalties on franchise retail sales; and

º (3)
º franchise fees, which we charge for initial franchise awards, renewals and transfers of franchises.

Although we do not anticipate the number of our domestic franchise stores to grow substantially, we expect to achieve domestic franchise store revenue growth consistent with projected industry growth, which we expect to generate from royalties on franchise retail sales and


Table of Contents

product sales to our existing franchisees. As a result of our efforts to expand our international presence and provisions in our international franchising agreements requiring franchisees to open additional stores, we have increased our international store base in recent periods and expect to continue to increase the number of our international franchise stores over the next five years. We believe this will result in additional franchise fees associated with new store openings and increased revenues from product sales to, and royalties from, new franchisees. Since our international franchisees pay royalties to us in U.S. dollars, any strengthening of the U.S. dollar relative to our franchisees' local currency may offset some of the growth in royalty revenue.

º •
º Manufacturing/Wholesale: Manufacturing/wholesale revenues are generated by sales of manufactured products to third parties, generally for third-party private label brands, the sale of our proprietary and third-party products to and through Rite Aid and www.drugstore.com and the sale of our proprietary products to PetSmart and Sam's Club. We also record license fee revenue from the opening of franchise store-within-a-store locations within Rite Aid stores. Our revenues generated by our manufacturing and wholesale operations are subject to our available manufacturing capacity.

A significant portion of our business infrastructure is comprised of fixed operating costs. Our vertically-integrated distribution network and manufacturing capacity can support higher sales volume without significant incremental costs. We therefore expect our operating expenses to grow at a lesser rate than our revenues, resulting in positive operating leverage.

The following trends and uncertainties in our industry could affect our operating performance as follows:

º •
º broader consumer awareness of health and wellness issues and rising healthcare costs may increase the use of the products we offer and positively affect our operating performance;

º •
º interest in, and demand for, condition-specific products based on scientific research may positively affect our operating performance if we can timely develop and offer such condition-specific products;

º •
º the effects of favorable and unfavorable publicity on consumer demand with respect to the products we offer may have similarly favorable or unfavorable effects on our operating performance;

º •
º a lack of long-term experience with human consumption of ingredients in some of our products could create uncertainties with respect to the health risks, if any, related to the consumption of such ingredients and negatively affect our operating performance;

º •
º increased costs associated with complying with new and existing governmental regulation may negatively affect our operating performance; and

º •
º a decline in disposable income available to consumers may lead to a reduction in consumer spending and negatively affect our operating performance.

Results of Operations

The following information presented as of December 31, 2012 and 2011 and for the years ended December 31, 2012, 2011 and 2010 was derived from our audited consolidated financial statements and accompanying notes.

As discussed in Note 16, "Segments," to our audited consolidated financial statements, we evaluate segment operating results based on several indicators. The primary key performance indicators are revenues and operating income or loss for each segment. Segment revenues and operating income or loss, as evaluated by management, exclude certain items that are managed at the consolidated level, such as warehousing and transportation costs, impairments and other corporate costs. The following discussion


Table of Contents

compares the revenues and the operating income or loss by segment, as well as those items excluded from the segment totals.

Same store sales growth reflects the percentage change in same store sales in the period presented compared to the prior year period. Same store sales are calculated on a daily basis for each store and exclude the net sales of a store for any period if the store was not open during the same period of the prior year. We also include our internet sales, as generated only through GNC.com and www.drugstore.com, in our domestic retail company-owned domestic same store sales calculation. When a store's square footage has been changed as a result of reconfiguration or relocation in the same mall or shopping center, the store continues to be treated as a same store. If, during the period presented, a store was closed, relocated to a different mall or shopping center, or converted to a franchise store or a company-owned store, sales from that store up to and including the closing day or the day immediately preceding the relocation or conversion are included as same store sales as long as the store was open during the same period of the prior year. We exclude from the calculation sales during the period presented that occurred on or after the date of relocation to a different mall or shopping center or the date of a conversion.


Table of Contents

Results of Operations

                                                     Year Ended December 31,
(Dollars in millions and
percentages expressed as a
percentage of total net
revenue)                                2012                  2011                  2010
Revenues:
Retail                           $ 1,785.0      73.5 % $ 1,518.5      73.3 % $ 1,344.4      73.8 %
Franchise                            408.1      16.8 %     334.8      16.1 %     293.6      16.1 %
Manufacturing / Wholesale:
Intersegment revenues                263.2      10.8 %     224.1      10.8 %     209.5      11.5 %
Third Party                          236.9       9.7 %     218.9      10.6 %     184.2      10.1 %

Subtotal Manufacturing /
Wholesale                            500.1      20.5 %     443.0      21.4 %     393.7      21.6 %
Elimination of intersegment
revenue                             (263.2 )   -10.8 %    (224.1 )   -10.8 %    (209.5 )   -11.5 %

Total revenues                     2,430.0     100.0 %   2,072.2     100.0 %   1,822.2     100.0 %
Operating expenses:
Cost of sales, including
warehousing, distribution and
occupancy costs                    1,500.2      61.7 %   1,318.4      63.6 %   1,179.9      64.8 %
Compensation and related
benefits                             314.3      12.9 %     291.3      14.1 %     273.8      15.0 %
Advertising and promotion             62.3       2.6 %      52.9       2.5 %      51.7       2.8 %
Other selling, general and
administrative expenses              114.9       4.7 %     105.5       5.1 %      92.9       5.1 %
Transaction and strategic
alternative related costs              1.9       0.1 %      13.5       0.7 %       4.0       0.2 %
Amortization expense                   8.6       0.4 %       8.0       0.4 %       7.8       0.4 %
Foreign currency (gain) loss          (0.1 )     0.0 %       0.1       0.0 %      (0.3 )     0.0 %

Total operating expenses           2,002.1      82.4 %   1,789.7      86.4 %   1,609.8      88.3 %
Operating income:
Retail                               346.4      14.3 %     243.5      11.8 %     181.9      10.0 %
Franchise                            136.5       5.6 %     111.3       5.4 %      93.8       5.1 %
Manufacturing / Wholesale             95.5       3.9 %      82.2       4.0 %      69.4       3.8 %
Unallocated corporate and
other costs:
Warehousing and distribution
costs                                (63.3 )    -2.6 %     (60.6 )    -3.0 %     (55.0 )    -3.0 %
Corporate costs                      (85.3 )    -3.5 %     (80.4 )    -3.9 %     (73.7 )    -4.0 %
Transaction and strategic
alternative related costs             (1.9 )    -0.1 %     (13.5 )    -0.7 %      (4.0 )    -0.2 %

Subtotal unallocated corporate
and other costs, net                (150.5 )    -6.2 %    (154.5 )    -7.6 %    (132.7 )    -7.3 %

Total operating income               427.9      17.6 %     282.5      13.6 %     212.4      11.7 %
Interest expense, net                 47.6                  74.9                  65.4

Income before income taxes           380.3                 207.6                 147.0
Income tax expense                   140.1                  75.3                  50.4

Net income                       $   240.2             $   132.3             $    96.6


Note: The numbers in the above table have been rounded to millions. All calculations related to the Results of Operations for the year-over-year comparisons were derived from unrounded data and could occasionally differ immaterially if you were to use the table above for these calculations.


Table of Contents

Comparison of the Years Ended December 31, 2012 and 2011

Revenues

Our consolidated net revenues increased $357.8 million, or 17.3%, to $2,430.0 million for the year ended December 31, 2012 compared to $2,072.2 million in 2011. The increase was the result of increased sales in each of our segments.

Retail. Revenues in our Retail segment increased $266.5 million, or 17.6%, to $1,785.0 million for the year ended December 31, 2012 compared to $1,518.5 million in 2011. Domestic retail revenue increased $211.2 million due to an 11.5% increase in our same store sales, the opening of new stores, sales increases in the sports nutrition, vitamin and diet product categories, and an increase in sales from GNC.com of $23.5 million, or 28.9%, to $104.5 million in 2012 compared to $81.1 million for 2011. In addition, sales from LuckyVitamin.com contributed $42.2 million to the increase in domestic retail revenue. Canadian sales increased by $13.1 million in U.S. dollars in 2012 compared to 2011. Our company-owned store base increased by 142 domestic stores to 3,021 at December 31, 2012 compared to 2,879 at December 31, 2011, due to new store openings and franchise store acquisitions. There was no change to our Canadian store base, with 167 stores at December 31, 2012 and December 31, 2011.

Franchise. Revenues in our Franchise segment increased $73.3 million, or 21.9%, to $408.1 million for the year ended December 31, 2012 compared to $334.8 million in 2011. Domestic franchise revenues increased $32.6 million to $239.9 million for the year ended December 31, 2012 compared to $207.3 million in 2011, primarily due to higher product sales, royalties and fees. Our domestic franchise same store sales for the year ended December 31, 2012 increased by 15.0% from 2011. There were 949 domestic franchise stores at December 31, 2012 compared to 924 stores at December 31, 2011. International franchise revenue increased by $42.7 million, to $168.2 million for the year ended December 31, 2012 from $125.5 million in 2011, primarily as a result of increases in product sales, royalties and fees. Our international franchise store base increased by 240 stores to 1,830 at December 31, 2012 compared to 1,590 at December 31, 2011.

Manufacturing/Wholesale. Revenues in our Manufacturing/Wholesale segment, which includes third-party sales from our manufacturing facilities in South Carolina, as well as wholesale sales to Rite Aid, PetSmart, Sam's Club and www.drugstore.com, increased by $18.0 million, or 8.2%, to $236.9 million for the year ended December 31, 2012 compared to $218.9 million in 2011. Third party contract manufacturing sales from our South Carolina manufacturing plant increased by $5.7 million, or 4.8%, to $123.9 million for the year ended December 31, 2012 compared to $118.2 million in 2011.

Cost of Sales

Cost of sales, which includes product costs, costs of warehousing and distribution and occupancy costs, increased $181.8 million, or 13.8%, to $1,500.2 million for the year ended December 31, 2012 compared to $1,318.4 million in 2011. Cost of sales, as a percentage of net revenue, was 61.7% and 63.6% for the year ended December 31, 2012 and 2011, respectively. The decrease in cost of sales as a percentage of net revenue was primarily driven by an increase in retail gross product margin, occupancy leverage, and a positive mix shift within wholesale and proprietary product sales.

Selling, General and Administrative ("SG&A") Expenses

SG&A expenses, including compensation and related benefits, advertising and promotion expense, other SG&A expenses, amortization expense and transaction and strategic alternative related costs, increased $30.2 million, or 6.4%, to $501.4 million, for the year ended December 31, 2012 compared to $471.2 million in 2011. These expenses, as a percentage of net revenue, were 20.6% for the year ended December 31, 2012 compared to 22.7% in 2011.


Table of Contents

Compensation and related benefits. Compensation and related benefits increased $23.0 million, or 7.9%, to $314.3 million for the year December 31, 2012 compared to $291.3 million in 2011. The increase was due primarily to our increased store base and sales volume.

Advertising and promotion. Advertising and promotion expenses increased $9.4 million, or 17.7%, to $62.3 million for the year ended December 31, 2012 compared to $52.9 million in 2011. The increase in advertising and promotion expense was primarily the result of increases in media expense, events and promotions.

Other SG&A. Other SG&A expenses, including amortization expense, increased $10.0 million, or 8.8%, to $123.5 million for the year ended December 31, 2012 compared to $113.5 million in 2011. This increase was due to increases in sales volume, legal expenses and other SG&A expenses.

Transaction and strategic alternative related costs. For the years ended December 31, 2012 and 2011, we incurred $1.9 million and $13.5 million, respectively, of expenses principally related to the Offerings and the Refinancings.

Operating Income

As a result of the foregoing, consolidated operating income increased $145.4 million, or 51.5%, to $427.9 million for the year ended December 31, 2012 compared to $282.5 million in 2011. Operating income, as a percentage of net revenue, was 17.6% and 13.6% for the years ended December 31, 2012 and 2011, respectively. Excluding transaction related expenses and executive severance, operating income was $429.8 million, or 17.7% of revenue, for the year ended December 31, 2012, as compared to $299.5 million, or 14.5% of revenue, for the year ended December 31, 2011.

Retail. Operating income increased $102.9 million, or 42.3%, to $346.4 million for the year ended December 31, 2012 compared to $243.5 million in 2011. The increase was driven by higher gross margin and expense leverage in occupancy, payroll, and other SG&A expenses.

Franchise. Operating income increased $25.2 million, or 22.7%, to $136.5 million for the year ended December 31, 2012 compared to $111.3 million in 2011. The increase was mostly due to increased wholesale product sales and royalty income.

Manufacturing/Wholesale. Operating income increased $13.3 million, or 16.2%, to $95.5 million for the year ended December 31, 2012 compared to $82.2 million in 2011. The increase was driven by a higher gross product margin resulting from improved wholesale margins and increased shipments of proprietary products.

Warehousing and distribution costs. Unallocated warehousing and distribution costs increased $2.7 million, or 4.6%, to $63.3 million for the year ended December 31, 2012 compared to $60.6 million in 2011. This increase was primarily due to higher fuel costs and increased wages to support higher sales volumes.

Corporate costs. Corporate overhead costs increased $4.9 million, or 6.1%, to $85.3 million for the year ended December 31, 2012 compared to $80.4 million in 2011. This increase was due to increases in compensation expense, health insurance, and other SG&A expenses offset by executive severance expense of $3.5 million.

Transaction and strategic alternative related costs. For the years ended December 31, 2012 and 2011, we incurred $1.9 million and $13.5 million, respectively, of expenses principally related to the Offerings and the Refinancings.


Table of Contents

Interest Expense

Interest expense decreased $27.3 million, or 36.5%, to $47.6 million for the year ended December 31, 2012 compared to $74.9 million in 2011. This decrease was primarily related to $23.2 million of costs in 2011 related to the Refinancings consisting of $5.8 million related to the termination of interest rate swaps, $13.4 million of deferred financing fees related to former indebtedness, $1.6 million in original issue discount related to the Senior Subordinated Notes and $2.4 million related to the defeasance of the Senior Notes and Senior Subordinated Notes. Additionally, we recognized $4.9 million of original issue discount and deferred financing fees expense related to the $300.0 million pay down of debt in connection with the IPO. During 2012, the Company incurred $3.2 million of costs related to the Refinancings. The decrease in overall interest rates also contributed to the decrease in interest expense.

Income Tax Expense

We recognized $140.1 million (or 36.8% of pre-tax income) of income tax expense for the year ended December 31, 2012 compared to $75.3 million (or 36.3% of pre-tax income) in 2011. The 2012 and 2011 income tax expense includes $0.7 million and $2.3 million, or 0.2% and 1.5% of pretax income, related to non-deductible costs, respectively. Income tax expense for the years ended December 31, 2012 and 2011 was reduced by valuation allowance adjustments of $1.2 million and $1.5 million, respectively. These valuation allowance adjustments reflected a change in circumstances that caused a change in judgment about the realizability of certain deferred tax assets related to state and foreign net operating losses. Also, for 2011, income tax expense was favorably impacted by $2.6 million related to non-recurring tax credits.

Net Income

As a result of the foregoing, consolidated net income increased $107.9 million, or 81.6%, to $240.2 million for the year ended December 31, 2012 compared to $132.3 million in 2011. Net income for the year ended December 31, 2012 includes $1.9 million of transaction related expense, net of tax effect, related to the Offerings and the Refinancings. For the year ended December 31, 2012, excluding transaction related expenses related to the Offerings and the Refinancings, net income, net of tax effect, was $242.1 million.

Comparison of the Years Ended December 31, 2011 and 2010

Revenues

Our consolidated net revenues increased $250.0 million, or 13.7%, to $2,072.2 million for the year ended December 31, 2011 compared to $1,822.2 million in 2010. The increase was the result of increased sales in each of our segments.

Retail. Revenues in our Retail segment increased $174.1 million, or 13.0%, to $1,518.5 million for the year ended December 31, 2011 compared to $1,344.4 million in 2010. Domestic retail revenue increased $156.2 million due . . .

  Add GNC to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for GNC - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.